Dr. Andrew Tidball’s work in the Parent lab involves modeling severe genetic epilepsies in neurons from patient-derived induced pluripotent stem (iPS) cells. He uses gene-editing techniques to generate isogenic controls and “virtual” patient iPS cell lines that he differentiates into neurons for functional analysis. In this webinar, Dr. Tidball discusses current and potential uses of iPS cells for modeling epilepsies, how to develop different iPS cell-based model systems, as well as the key advantages and drawbacks of using these model systems.
To view the webinar, please complete the form, or sign in to your account.
StemCell Technologies Inc. and affiliates ("STEMCELL Technologies") does not share your email address with third parties. StemCell Technologies Inc. will use your email address to confirm your identity and send you newsletters, transaction-related emails, promotional and customer service emails in accordance with our privacy policy. You can change your email preferences at any time.